8 July 2022 - - Netherlands-based professional information, software solutions, and services provider Wolters Kluwer's Wolters Kluwer Health business has expanded Ovid with SRI International's BioCyc, a collection of more than 20,000 organism-centric Pathway/Genome Databases (PGDBs) and bioinformatics software tools, the firm said.

As the world's most trusted medical research platform, Ovid offers premium aggregated content and productivity tools, including resources from over 120 publishers in more than 100 specialty areas.

SRI International is an independent, nonprofit research organization that has been supporting the discovery and design of ground-breaking products and technologies for over 75 years.

Produced by SRI's Bioinformatics Research Group, BioCyc provides an encyclopedic reference on the genomes, metabolic pathways, and regulatory networks of thousands of sequenced organisms from all domains of life, as well as data access, searching, analysis, and visualization tools.

Sources of the data include computational inferences, data from other databases, and literature-based curation derived from over 130,000 peer-reviewed publications.

BioCyc can be used in a broad range of applications, from nucleic acid biophysics and metabolic modeling of human microbiome organisms to drug and vaccine design and metabolic engineering.

Advances in sequencing technologies and bioinformatics have resulted in a deluge of genetic sequence data that is being used to greatly enhance the understanding of living systems.

Additionally, falling costs and faster turnaround times are enabling academic, nonprofit, commercial, and government researchers to use genetic data in drug discovery, agriculture, biotechnology, and other fields.

By adding BioCyc access to Ovid, Wolters Kluwer said it is enabling researchers to take advantage of this genomic information and more easily fulfill the promise it holds for clinical and academic research.

With access to BioCyc's PGDBs and software-based tools on Ovid's platform, researchers can easily take advantage of the latest developments in pathway and genomics data.

BioCyc is a natural fit for omics researchers. The Ovid platform's breadth is ideally suited for the fast-evolving, multi-disciplinary research that bring together genomics, epigenomics, transcriptomics, proteomics, metabolomics, and other fields.

Wolters Kluwer is in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors.

We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2021 annual revenues of EUR 4.8bn. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide.

The company is headquartered in Alphen aan den Rijn, the Netherlands.